Abstract 510P
Background
Glioblastoma (GBM) is the most common and aggressive form of primary brain tumor with poor survival rates. While conventional therapies including surgery, chemotherapy, and radiotherapy extend patient survival, recurrence within 6-9 months is common with no effective therapy. Thus, novel treatment strategies that have greater specificity and efficacy are warranted. Analyzing the Ivy Glioblastoma Atlas Project's transcriptomics data based on anatomic structures (http://www.brain-map.org/), we identified that CD47, a ubiquitously expressed receptor known to block phagocytosis by interacting with SIRPα on myeloid cells, is abundantly expressed on the leading invasive edge of GBM patient tumors. Increased expression of CD47 is also associated with poorer survival in GBM patients. Importantly, the role of CD47 in GBM besides promoting immune escape is not well understood. Therefore, we propose to identify cell-intrinsic mechanisms that CD47 regulates in GBM.
Methods
To identify intracellular mechanisms regulated by CD47 in GBM, we created a CD47 CRISPR knock-out (KO) cell line using U87 GBM cells. Using the control and CD47 KO cells, we performed a clonogenic assay and transwell migration assay to assess changes in cellular phenotype. Subsequently, we performed bulk RNA-seq followed by gene set enrichment analysis to identify pathways regulated by CD47. To address changes in cell metabolism, a seahorse assay followed by non-targeted metabolomics and metabolic flux analysis was also conducted.
Results
We have found that loss of CD47 in GBM cells reduces cell migration and proliferation in the absence of myeloid cells, suggesting a cell-autonomous function of CD47. Consistently, gene set enrichment analysis in control and CD47 KO GBM cells indicates that cell polarity, axonal guidance, cell differentiation, and cell proliferation pathways are driven by CD47 signaling. Furthermore, our data shows that CD47 regulates metabolic plasticity. We found that CD47 KO cells exhibit elevated levels of several glycolytic metabolites which correlates with increased mitochondrial spare respiratory capacity and mitochondrial biogenesis.
Conclusions
We have identified a novel immune-independent function of CD47 in linking cellular and metabolic plasticity in GBM.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
University of South Australia.
Funding
Neurosurgical Research Foundation.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
88P - PPM1D/WIP1 phosphatase mediates basal and genotoxic stress-induced autophagy via ULK-1 de-phosphorylation
Presenter: Ceylan Ak
Session: Poster session 09
89P - Cold atmospheric plasma-activated fluids as a potential new intravesical agent for the treatment of bladder cancer
Presenter: Maria Filomena Botelho
Session: Poster session 09
90P - Discovery of CMPD1 as a tumor-specific cytotoxic microtubule inhibitor
Presenter: Mamoru Takada
Session: Poster session 09
91P - Erythroid precursor-differentiated myeloid cells promote pulmonary metastasis in hepatocellular carcinoma
Presenter: Wei-hang Zhu
Session: Poster session 09
92P - Discovery of novel AXL and MER inhibitors as potential anticancer and immune modulator drugs
Presenter: Hsing-Pang Hsieh
Session: Poster session 09
93P - Transcriptome changes of immune cells across chemotherapy of triple-negative breast cancer
Presenter: Tatiana Gerashchenko
Session: Poster session 09
509P - Spatial analysis of tumor-associated macrophages within the tumor microenvironment of primary tumors and matched brain metastases
Presenter: Markus Kleinberger
Session: Poster session 09
511P - Immunodisruptive conditions and glioma diagnosis: 24-year retrospective study of an under-recognized scenario
Presenter: Santiago Cabezas-Camarero
Session: Poster session 09
512P - Heterozygous germline Fanconi anemia-related gene mutations increase susceptibility to central nervous system germ cell tumors
Presenter: Guangyu Wang
Session: Poster session 09
513P - Cyclin pathway in oligodendrogliomas IDH mut and 1p/19q codeleted
Presenter: Maria Angeles Vaz Salgado
Session: Poster session 09